DENS develops and produces energy systems based upon the LOHC Hydrozine
DENS has raised $11.3M in total funding. The most recent round was Series A. The last funding was announced in October 2021.
DENS's investors include European Innovation Council, Koolen Industries.
DENS is headquartered in Helmond, The Netherlands.
DENS develops and produces energy systems based upon the LOHC Hydrozine
DENS is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"DENS — Funding & Investors." VCBacked, October 25, 2021, https://www.vcbacked.co/company/dens. Accessed September 16, 2026.
VCBacked. (2021). DENS — Funding & Investors. Retrieved September 16, 2026, from https://www.vcbacked.co/company/dens
{{cite web |title=DENS — Funding & Investors |url=https://www.vcbacked.co/company/dens |website=VCBacked |access-date=September 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated